6-KThe Wire
TAKEDA PHARMACEUTICAL CO LTD files 6-K
Filed May 13, 2026 · 1mo ago · Accession 0001395064-26-000145
Plain English
For the fiscal year ended March 31, 2025 (FY2025), Takeda Pharmaceutical Company Limited reported net profit attributable to owners of the Company of JPY 191.8 billion, an increase of JPY 83.8 billion or 77.7% from FY2024. Operating profit for FY2025 was JPY 408.8 billion, an increase of JPY 66.2 billion or 19.3% from FY2024.
Filing details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Ticker
- TAK
- CIK
- 1395064
- Form type
- 6-K
- Filing date
- May 13, 2026
- Report date
- May 13, 2026
- Document
- exhibit991_051326.htm
- Size
- 1.7 MB